vs
ONESPAWORLD HOLDINGS Ltd（OSW）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
ONESPAWORLD HOLDINGS Ltd的季度营收约是REPLIGEN CORP的1.2倍（$242.1M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 5.0%，领先1.7%），REPLIGEN CORP同比增速更快（13.6% vs 11.5%），REPLIGEN CORP自由现金流更多（$17.6M vs $14.9M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 7.1%）
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
OSW vs RGEN — 直观对比
营收规模更大
OSW
是对方的1.2倍
$197.9M
营收增速更快
RGEN
高出2.2%
11.5%
净利率更高
RGEN
高出1.7%
5.0%
自由现金流更多
RGEN
多$2.6M
$14.9M
两年增速更快
RGEN
近两年复合增速
7.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $242.1M | $197.9M |
| 净利润 | $12.1M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 6.8% | 9.0% |
| 净利率 | 5.0% | 6.7% |
| 营收同比 | 11.5% | 13.6% |
| 净利润同比 | -16.2% | 143.9% |
| 每股收益（稀释后） | $0.12 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OSWRGEN
| Q4 25 | $242.1M | $197.9M | ||
| Q3 25 | $258.5M | $188.8M | ||
| Q2 25 | $240.7M | $182.4M | ||
| Q1 25 | $219.6M | $169.2M | ||
| Q4 24 | $217.2M | $174.1M | ||
| Q3 24 | $241.7M | $154.9M | ||
| Q2 24 | $224.9M | $154.1M | ||
| Q1 24 | $211.2M | $151.3M |
净利润OSWRGEN
| Q4 25 | $12.1M | $13.3M | ||
| Q3 25 | $24.3M | $14.9M | ||
| Q2 25 | $19.9M | $14.9M | ||
| Q1 25 | $15.3M | $5.8M | ||
| Q4 24 | $14.4M | $-30.3M | ||
| Q3 24 | $21.6M | $-654.0K | ||
| Q2 24 | $15.8M | $3.3M | ||
| Q1 24 | $21.2M | $2.1M |
毛利率OSWRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率OSWRGEN
| Q4 25 | 6.8% | 9.0% | ||
| Q3 25 | 10.2% | 8.9% | ||
| Q2 25 | 9.2% | 7.6% | ||
| Q1 25 | 7.7% | 3.9% | ||
| Q4 24 | 7.9% | -17.7% | ||
| Q3 24 | 10.3% | -5.1% | ||
| Q2 24 | 8.4% | 1.0% | ||
| Q1 24 | 8.0% | 1.3% |
净利率OSWRGEN
| Q4 25 | 5.0% | 6.7% | ||
| Q3 25 | 9.4% | 7.9% | ||
| Q2 25 | 8.3% | 8.2% | ||
| Q1 25 | 7.0% | 3.4% | ||
| Q4 24 | 6.6% | -17.4% | ||
| Q3 24 | 8.9% | -0.4% | ||
| Q2 24 | 7.0% | 2.2% | ||
| Q1 24 | 10.0% | 1.4% |
每股收益（稀释后）OSWRGEN
| Q4 25 | $0.12 | $0.24 | ||
| Q3 25 | $0.23 | $0.26 | ||
| Q2 25 | $0.19 | $0.26 | ||
| Q1 25 | $0.15 | $0.10 | ||
| Q4 24 | $0.13 | $-0.55 | ||
| Q3 24 | $0.20 | $-0.01 | ||
| Q2 24 | $0.15 | $0.06 | ||
| Q1 24 | $0.21 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $16.3M | $767.6M |
| 总债务越低越好 | $84.0M | $542.2M |
| 股东权益账面价值 | $542.6M | $2.1B |
| 总资产 | $707.1M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.15× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资OSWRGEN
| Q4 25 | $16.3M | $767.6M | ||
| Q3 25 | $29.6M | $748.7M | ||
| Q2 25 | $35.0M | $708.9M | ||
| Q1 25 | $22.6M | $697.2M | ||
| Q4 24 | $57.4M | $757.4M | ||
| Q3 24 | $48.8M | $784.0M | ||
| Q2 24 | $62.5M | $809.1M | ||
| Q1 24 | $65.4M | $780.6M |
总债务OSWRGEN
| Q4 25 | $84.0M | $542.2M | ||
| Q3 25 | $85.2M | $537.9M | ||
| Q2 25 | $96.2M | — | ||
| Q1 25 | $97.4M | — | ||
| Q4 24 | $98.6M | $525.6M | ||
| Q3 24 | $98.7M | — | ||
| Q2 24 | $123.8M | — | ||
| Q1 24 | $138.6M | — |
股东权益OSWRGEN
| Q4 25 | $542.6M | $2.1B | ||
| Q3 25 | $552.8M | $2.1B | ||
| Q2 25 | $548.3M | $2.1B | ||
| Q1 25 | $530.6M | $2.0B | ||
| Q4 24 | $554.5M | $2.0B | ||
| Q3 24 | $540.1M | $2.0B | ||
| Q2 24 | $532.7M | $2.0B | ||
| Q1 24 | $515.5M | $2.0B |
总资产OSWRGEN
| Q4 25 | $707.1M | $2.9B | ||
| Q3 25 | $732.6M | $2.9B | ||
| Q2 25 | $731.8M | $2.9B | ||
| Q1 25 | $708.7M | $2.9B | ||
| Q4 24 | $746.4M | $2.8B | ||
| Q3 24 | $734.0M | $2.8B | ||
| Q2 24 | $756.8M | $2.9B | ||
| Q1 24 | $763.6M | $2.8B |
负债/权益比OSWRGEN
| Q4 25 | 0.15× | 0.26× | ||
| Q3 25 | 0.15× | 0.26× | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.18× | — | ||
| Q4 24 | 0.18× | 0.27× | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | 0.23× | — | ||
| Q1 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $14.9M | $17.6M |
| 自由现金流率自由现金流/营收 | 6.2% | 8.9% |
| 资本支出强度资本支出/营收 | 2.1% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.65× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $68.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流OSWRGEN
| Q4 25 | $20.0M | $25.7M | ||
| Q3 25 | $33.2M | $48.1M | ||
| Q2 25 | $20.3M | $28.6M | ||
| Q1 25 | $10.1M | $15.0M | ||
| Q4 24 | $16.6M | $39.2M | ||
| Q3 24 | $28.6M | $49.3M | ||
| Q2 24 | $18.7M | $42.2M | ||
| Q1 24 | $15.0M | $44.7M |
自由现金流OSWRGEN
| Q4 25 | $14.9M | $17.6M | ||
| Q3 25 | $27.6M | $43.4M | ||
| Q2 25 | $17.6M | $21.5M | ||
| Q1 25 | $8.4M | $11.4M | ||
| Q4 24 | $13.2M | $33.6M | ||
| Q3 24 | $27.5M | $42.3M | ||
| Q2 24 | $17.6M | $37.4M | ||
| Q1 24 | $13.7M | $36.4M |
自由现金流率OSWRGEN
| Q4 25 | 6.2% | 8.9% | ||
| Q3 25 | 10.7% | 23.0% | ||
| Q2 25 | 7.3% | 11.8% | ||
| Q1 25 | 3.8% | 6.8% | ||
| Q4 24 | 6.1% | 19.3% | ||
| Q3 24 | 11.4% | 27.3% | ||
| Q2 24 | 7.8% | 24.3% | ||
| Q1 24 | 6.5% | 24.0% |
资本支出强度OSWRGEN
| Q4 25 | 2.1% | 4.1% | ||
| Q3 25 | 2.2% | 2.5% | ||
| Q2 25 | 1.1% | 3.9% | ||
| Q1 25 | 0.8% | 2.1% | ||
| Q4 24 | 1.5% | 3.2% | ||
| Q3 24 | 0.5% | 4.5% | ||
| Q2 24 | 0.5% | 3.1% | ||
| Q1 24 | 0.6% | 5.5% |
现金转化率OSWRGEN
| Q4 25 | 1.65× | 1.93× | ||
| Q3 25 | 1.36× | 3.23× | ||
| Q2 25 | 1.02× | 1.92× | ||
| Q1 25 | 0.66× | 2.57× | ||
| Q4 24 | 1.15× | — | ||
| Q3 24 | 1.33× | — | ||
| Q2 24 | 1.19× | 12.70× | ||
| Q1 24 | 0.71× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OSW
| Services | $197.3M | 82% |
| Products | $44.8M | 18% |
RGEN
暂无分部数据
